Recently, ARID1A mutations and loss of BAF250a protein have been found to correlate strongly with the ovarian clear-cell carcinoma and uterine low-grade endometrioid carcinoma [11]–[13]. The gene discussed is ARID1A; the disease is ovarian clear cell cancer.